Indoco Remedies Limited (NSE:INDOCO)
India · Delayed Price · Currency is INR 250.05
-11.62 (-4.44%)
Oct 1, 2026, 3:29 PM IST
Indoco Remedies Market Cap
Indoco Remedies has a market cap or net worth of 23.24 billion as of October 1, 2026. Its market cap has decreased by -13.72% in one year.
Market Cap
23.24B
Enterprise Value
33.73B
Revenue
18.73B
Ranking
n/a
PE Ratio
412.74
Stock Price
250.05
ChartMarket Cap Chart
Since January 14, 2005, Indoco Remedies's market cap has increased from 4.66B to 23.24B, an increase of 398.65%. That is a compound annual growth rate of 7.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 23.24B | 7.38% |
| Dec 31, 2025 | 21.64B | -29.33% |
| Dec 31, 2024 | 30.62B | -15.91% |
| Dec 29, 2023 | 36.42B | -2.82% |
| Dec 30, 2022 | 37.47B | -10.49% |
| Dec 31, 2021 | 41.86B | 49.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orchid Pharma | 51.91B |
| RPG Life Sciences | 48.87B |
| Solara Active Pharma Sciences | 35.53B |
| Ind-Swift Laboratories | 35.49B |
| Sakar Healthcare | 24.24B |
| Windlas Biotech | 22.75B |
| Beta Drugs | 20.68B |
| Anlon Healthcare | 18.42B |